RCP168 is a highly selective and affinity CXCR4 receptor antagonist (IC50=5 nM). RCP168 has a stronger ability than natural chemical factors to inhibit the entry of HIV-1 (human immunodeficiency virus type 1) into host cells via CXCR4 receptors. RCP168 inhibits HIV-1 infection by blocking viral binding sites or inducing receptor internalization. RCP168 can be used to analyze the interaction between CXCR4 receptor and other chemical factor receptors[1].
Molecular Weight:
8124.52
Formula:
C365H585N105O95S5
Target:
CXCR
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
